The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The database contains 6711 drug entries including 1441 FDA-approved small molecule drugs, 134 FDA-approved biotech (protein/peptide) drugs, 84 nutraceuticals and 5084 experimental drugs. Additionally, 4231 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 150 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.
DrugBank is supported by David Wishart, Departments of Computing Science & Biological Sciences, University of Alberta.
DrugBank is also supported by The Metabolomics Innovation Centre, a Genome Canada-funded core facility serving the scientific community and industry with world-class expertise and cutting-edge technologies in metabolomics.